Relaxin as a potential diagnostic biomarker for ovarian cancer- A prospective study. Gkrozou F, Pappa C, Tsonis O, Dimitriou E, et al. Eur J Obstet Gynecol Reprod Biol 2021;260:99-104.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Gkrozou F, Pappa C, Tsonis O, Dimitriou E, et al. Relaxin as a potential diagnostic biomarker for ovarian cancer- A prospective study. Eur J Obstet Gynecol Reprod Biol 2021;260:99-104.
PMID: 33752121